Lilly(Eli) & Company
NYSE: LLY
$725.72
-$31.88 (-4.2%)
Closing Price on January 17, 2025
LLY Articles
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
Published:
Last Updated:
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
Published:
Last Updated:
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Published:
Last Updated:
Volumes tend to dry up in the summer as traders and investors go on vacation, making it all that much easier for the short-sellers to exploit headline and market risk.
Published:
Last Updated:
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Published:
Last Updated:
With a flight to cash hardly workable for most investors, and Treasury bonds seemingly very rich, quality low-volatility dividend stocks make the most sense in for uncertain times.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer and SolarCity.
Published:
Last Updated:
Eli Lilly is set to release its first-quarter earnings report before the markets open on Tuesday.
Published:
Last Updated:
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
Published:
Last Updated:
In a new research report, Credit Suisse highlighted some companies on its U.S. Focus List that stand to have the most potential price return.
Published:
Last Updated:
These four solid companies to buy and hold all can do well, and even if the market sells off, the demand for their products and services will not. Plus, they all offer a dividend.
Published:
Last Updated:
24/7 Wall St. has identified seven companies that could easily reach the $100 billion mark to become the next mega-cap stocks.
Published:
Last Updated:
March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped...
Published:
Last Updated:
March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.